Abstract
Cramizol, an imidazole derivative, exhibits lipid-lowering and anti-atherogenic effects. In animals with acute hyperlipidemia induced by Triton WR-1339 cramizol reduced blood levels of cholesterol and triglycerides, and also the atherogenic index. Cramizol and the lipid-lowering drug fenofibrate demonstrated similar effectiveness as hypolipidemic agents. Cramizol also restored the expression of the Apoa1 gene in rats with experimentally induced hyperlipidemia to normal values. This may be a basis of its hypolipidemic and anti-atherogenic action.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry
Paper Title
Journal
Date
